Establishment Labs today announced that it has appointed Raj Denhoy as chief financial officer, effective immediately.
Denhoy has been with the Santa Barbara, Calif.-based company since February when he was appointed as head of strategy and investor relations. He has served as interim chief financial officer since August.
“Raj has quickly become a trusted and vital colleague to me and many others at Establishment Labs,” founder and CEO Juan José Chacón-Quirós said in a news release. “His depth of knowledge about our business and industry is matched by a clear vision of what we must do to achieve success as a global leader in women’s health. After discussions with a number of qualified candidates during this process, I could not be more pleased that Raj has accepted the position of our chief financial officer.”
Prior to joining the company, Denhoy was a managing director at Jefferies Group where he led the U.S. medical device research team for 11 years. He has also covered the medical device industry as an equity research analyst for over 20 years.
“I am grateful every day to be part of the exceptional team at Establishment Labs,” Denhoy said. “What we have accomplished already is significant, but the next chapter in our story will be even more consequential. It is within our reach to become not only the leading global company in breast aesthetics and reconstruction but to fundamentally transform and expand these markets through science and consumer-centric innovation. It is a privilege to be taking on this expanded role as we work to create value for all our stakeholders.”